However, in the RA subjects, the percentages of the two subsets were not significantly different because there was an increase in the percentage of the CD19+CD5+TLR10+ B cells and a decrease in the percentage of CD19+CD5−TLR10+ B cells. This evidence concerns the gene TLR10 and rheumatoid arthritis.